1-(Dimethylamino)-3-methylbutan-1-ol

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-(Dimethylamino)-3-methylbutan-1-ol
• 英文别名: 1-(dimethylamino)-3-methylbutan-1-ol
• 化学式: C₇H₁₇NO
• 分子量: 131.22
• InChiKey: UAYZTWBEBYNQQG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Lactam Compound, Preparation Method and Use thereof
  申请人：OCEAN UNIVERSITY OF CHINA

  公开号：US20200030312A1

  公开（公告）日：2020-01-30

  Provided is a lactam compound, a tautomer, a stereoisomer, a racemate, a nonequal mixture of enantiomers, a geometric isomer, a solvate, a pharmaceutically acceptable salt thereof, or a solvate of the salt of the compound, and a pharmaceutical composition containing the compound. Also provided are the use of such compounds and their pharmaceutical compositions as drugs, especially as antiviral drugs.

  提供一种内酰胺化合物，一个互变异构体，一个立体异构体，一个拉克酸盐，一个非对映异构体的不等混合物，一个几何异构体，一个溶剂合物，其药学上可接受的盐，或者该化合物的盐的溶剂合物，以及含有该化合物的药物组合物。还提供了这些化合物及其药物组合物作为药物的用途，尤其是作为抗病毒药物。
• Penicinotam derivative, preparation method and use thereof
  申请人：OCEAN UNIVERSITY OF CHINA

  公开号：US11040028B2

  公开（公告）日：2021-06-22

  Provided are penicinotam derivatives, a tautomer, a stereoisomer, a racemate, a nonequal mixture of enantiomers, a geometric isomer, a solvate, a pharmaceutically acceptable salt or a prodrug thereof, and a pharmaceutical composition comprising the derivatives. Also provided herein is use of the derivatives and the pharmaceutical compositions in treating diseases caused by inflammation, immune system disorders.

  本文提供了青霉胺衍生物、同分异构体、立体异构体、外消旋体、对映体的非等价混合物、几何异构体、溶液、其药学上可接受的盐或原药，以及包含这些衍生物的药物组合物。本文还提供了这些衍生物和药物组合物在治疗炎症引起的疾病、免疫系统疾病中的用途。
• HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE
  申请人：Board of Regents, University of Texas System

  公开号：US20170121342A1

  公开（公告）日：2017-05-04

  The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.
• PRODRUGS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITOR
  申请人：THE JOHNS HOPKINS UNIVERSITY

  公开号：US20170226141A1

  公开（公告）日：2017-08-10

  Methods and compounds are disclosed for treating a disease or condition by inhibiting PSMA (Prostate Specific Membrane Antigen) using prodrugs of 2-PMPA.
• [EN] PRMT5 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE PRMT5 ET LEURS UTILISATIONS
  申请人：EPIZYME INC

  公开号：WO2014100719A2

  公开（公告）日：2014-06-26

  Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5 mediated disorders are also described.